Literature DB >> 29450360

Choroidal melanoma suspect. Conservative treatment and evolution. Case report.

Mihail Zemba1,2, Radu Alexandru Malciolu1.   

Abstract

We present the case of a 42-year-old female who presented to our clinic for phosphenes in the left eye, occurring along with eye movement. A diagnosis of choroidal melanoma suspect was made. Due to the patient's profile, young, active woman, surgeon, and the limited therapeutic options in Romania, a conservative treatment and brachytherapy were chosen, which were successfully performed abroad. The patient has been followed-up, so far, for five years after the procedure, with spectacular results.

Entities:  

Keywords:  brachytherapy; choroidal melanoma; radiation retinopathy; radiation therapy

Mesh:

Substances:

Year:  2016        PMID: 29450360      PMCID: PMC5711292     

Source DB:  PubMed          Journal:  Rom J Ophthalmol        ISSN: 2457-4325


  12 in total

Review 1.  The Zimmerman-McLean-Foster hypothesis: 25 years later.

Authors:  A D Singh; I G Rennie; T Kivela; S Seregard; H Grossniklaus
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

Review 2.  Radiation therapy for orbital tumors: concepts, current use, and ophthalmic radiation side effects.

Authors:  Paul T Finger
Journal:  Surv Ophthalmol       Date:  2009 Sep-Oct       Impact factor: 6.048

3.  Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study.

Authors:  Paul T Finger; Kimberly J Chin; Ekaterina A Semenova
Journal:  Eur J Ophthalmol       Date:  2015-09-19       Impact factor: 2.597

4.  Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1.

Authors: 
Journal:  Arch Ophthalmol       Date:  1990-09

5.  Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma.

Authors:  K Gündüz; C L Shields; J A Shields; J Cater; J E Freire; L W Brady
Journal:  Arch Ophthalmol       Date:  1999-05

6.  Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15.

Authors: 
Journal:  Arch Ophthalmol       Date:  2001-05

Review 7.  Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells.

Authors:  L E Zimmerman; I W McLean; W D Foster
Journal:  Br J Ophthalmol       Date:  1978-06       Impact factor: 4.638

8.  Very long-term prognosis of patients with malignant uveal melanoma.

Authors:  Emma Kujala; Teemu Mäkitie; Tero Kivelä
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

Review 9.  Choroidal melanoma: natural history and management options.

Authors:  Darren J Bell; Matthew W Wilson
Journal:  Cancer Control       Date:  2004 Sep-Oct       Impact factor: 3.302

10.  Prognosis and treatment of disseminated uveal melanoma.

Authors:  R Kath; J Hayungs; N Bornfeld; W Sauerwein; K Höffken; S Seeber
Journal:  Cancer       Date:  1993-10-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.